Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19.
Henderson MW, Lima F, Moraes CRP, Ilich A, Huber SC, Barbosa MS, Santos I, Palma AC, Nunes TA, Ulaf RG, Ribeiro LC, Bernardes AF, Bombassaro B, Dertkigil SSJ, Moretti ML, Strickland S, Annichino-Bizzacchi JM, Orsi FA, Mansour E, Velloso LA, Key NS, De Paula EV. Henderson MW, et al. Among authors: huber sc. Blood Adv. 2022 Jun 14;6(11):3367-3377. doi: 10.1182/bloodadvances.2021006620. Blood Adv. 2022. PMID: 35235941 Free PMC article.
Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban.
Ferreira T, Huber SC, de Moraes Martinelli B, Junior AL, Menezes FH, Orsi FA, Bittar LF, de Oliveira LFG, Sodre LR, Mello TT, Rielli G, Colella MP, de Paula EV, Yamaguti-Hayakawa GG, Montalvão S, Annichino-Bizzacchi JM. Ferreira T, et al. Among authors: huber sc. Vascul Pharmacol. 2020 Jan;124:106608. doi: 10.1016/j.vph.2019.106608. Epub 2019 Oct 31. Vascul Pharmacol. 2020. PMID: 31678199
Corrigendum to "Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban" [Vascular Pharmacology 124 (2020)/106608].
Ferreira T, Huber SC, de Moraes Martinelli B, Junior AL, Menezes FH, Orsi FA, Bittar LF, de Oliveira LFG, Sodre LR, Mello TT, Rielli G, Colella MP, de Paula EV, Yamaguti Hayakawa GG, Montalvão S, Annichino-Bizzacchi JM. Ferreira T, et al. Among authors: huber sc. Vascul Pharmacol. 2020 Oct-Nov;133-134:106780. doi: 10.1016/j.vph.2020.106780. Epub 2020 Aug 28. Vascul Pharmacol. 2020. PMID: 32868216 No abstract available.
Misdiagnosis of high thrombotic risk triple-positive antiphospholipid antibodies.
De Lima Montalvão SA, Colella MP, Fernandes MC, Huber SC, Francisco AP, Soares SM, Miranda LD, Aguiari HJ, Elídio PS, Yamaguti G, De Paula EV, Orsi FA, Annichinno-Bizzacchi JM. De Lima Montalvão SA, et al. Among authors: huber sc. Thromb Res. 2021 Jan;197:33-35. doi: 10.1016/j.thromres.2020.10.016. Epub 2020 Oct 23. Thromb Res. 2021. PMID: 33161285 No abstract available.
A case series of platelet rich plasma in chronic venous ulcers.
Huber SC, de Moraes Martinelli B, Quintero M, de Paula LÍS, Cataldo JL, de Lima Montalvão SA, Annichino-Bizzacchi JM. Huber SC, et al. Regen Ther. 2021 Apr 5;18:51-58. doi: 10.1016/j.reth.2021.03.005. eCollection 2021 Dec. Regen Ther. 2021. PMID: 33869687 Free PMC article.
210 results